The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Interaction of an NF-kappa B-like factor with a site upstream of the c-myc promoter.
Open accessAbstract
The c-myc protooncogene has been implicated in control of growth and differentiation of mammalian cells. For instance, growth arrest is often preceded by reduction in c-myc mRNA and gene transcription. To elucidate the mechanisms of control of c-myc gene transcription, we have begun to characterize the interaction of nuclear factors with the 719-base-pair (bp) c-myc regulatory domain, located 1139-421 bp upstream of the P1 start site of the mouse gene. Nuclear extracts from exponentially growing WEHI 231 murine B-lymphoma cells formed multiple complexes in mobility-shift assays. Changes in complex distribution were observed in growth-arrested WEHI 231 cells, and a major site of this interaction mapped to a 21-bp sequence that is similar to the sequences recognized by the NF-kappa B family of proteins. Binding of NF-kappa B-like factors was demonstrated by oligonucleotide competition. Induction of complex formation upon 70Z/3 pre-B- to B-cell differentiation, enhancement of binding by GTP, and detergent-induced release of inhibitor protein suggested that NF-kappa B itself is one member of the family that can bind. Transfection of thymidine kinase-chloramphenicol acetyltransferase constructs containing the 21-bp c-myc sequence into Jurkat cells demonstrated increased chloramphenicol acetyltransferase activity upon phorbol ester and phytohemagglutinin treatment. These results suggest the involvement of NF-kappa B-like factors in the regulation of c-myc transcription.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[57] Sequencing end-labeled DNA with base-specific chemical cleavages
Maxam, A. M., & Gilbert, W. (1980) · Methods in Enzymology · doi:10.1016/s0076-6879(80)65059-9 · Cited by 14,315
Multiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,752
IκB: a Specific Inhibitor of the NF-κB Transcription Factor
Baeuerle, P. A., & Baltimore, D. (1988) · Science · doi:10.1126/science.3140380 · Cited by 2,155
An inducible transcription factor activates expression of human immunodeficiency virus in T cells
Nabel, G., & Baltimore, D. (1987) · Nature · doi:10.1038/326711a0 · Cited by 2,041
Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90807-x · Cited by 1,993
NF-κB: A pleiotropic mediator of inducible and tissue-specific gene control
Lenardo, M. J., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90833-7 · Cited by 1,585
Immunoglobulin gene transcription is activated by downstream sequence elements
Queen, C., & Baltimore, D. (1983) · Cell · doi:10.1016/0092-8674(83)90016-8 · Cited by 791
Strauss, F., & Varshavsky, A. (1984) · Cell · doi:10.1016/0092-8674(84)90424-0 · Cited by 655
HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-κB-like factor
Leung, K., & Nabel, G. J. (1988) · Nature · doi:10.1038/333776a0 · Cited by 586
Protein-Binding Sites in Ig Gene Enhancers Determine Transcriptional Activity and Inducibility
Lenardo, M., Pierce, J. W., & Baltimore, D. (1987) · Science · doi:10.1126/science.3109035 · Cited by 578
Lenardo, M. J., Fan, C.-M., Maniatis, T., & Baltimore, D. (1989) · Cell · doi:10.1016/0092-8674(89)90966-5 · Cited by 473
Activation of the HIV-1 LTR by T Cell Mitogens and the Trans-Activator Protein of HTLV-I
Siekevitz, M., Josephs, S. F., Dukovich, M., Peffer, N., Wong-Staal, F., & Greene, W. C. (1987) · Science · doi:10.1126/science.2825351 · Cited by 452
Böhnlein, E., Lowenthal, J. W., Siekevitz, M., Ballard, D. W., Franza, B. R., & Greene, W. C. (1988) · Cell · doi:10.1016/0092-8674(88)90099-2 · Cited by 400
Kappa B-Specific DNA Binding Proteins: Role in the Regulation of Human Interleukin-2 Gene Expression
Hoyos, B., Ballard, D. W., Böhnlein, E., Siekevitz, M., & Greene, W. C. (1989) · Science · doi:10.1126/science.2497518 · Cited by 318
Baldwin, A. S., & Sharp, P. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.3.723 · Cited by 292
Kuwabara, M., & Sigman, D. S. (1987) · Biochemistry · doi:10.1021/bi00397a006 · Cited by 286
Atchison, M. L., & Perry, R. P. (1987) · Cell · doi:10.1016/0092-8674(87)90362-x · Cited by 232
A muscle-specific enhancer is located at the 3' end of the myosin light-chain 1/3 gene locus.
Donoghue, M., Ernst, H., Wentworth, B., Nadal-Ginard, B., & Rosenthal, N. (1988) · Genes & Development · doi:10.1101/gad.2.12b.1779 · Cited by 204
Developmental stage specificity of the lymphoid V(D)J recombination activity.
Lieber, M. R., Hesse, J. E., Mizuuchi, K., & Gellert, M. (1987) · Genes & Development · doi:10.1101/gad.1.8.751 · Cited by 189
Ballard, D., Bohnlein, E., Lowenthal, J., Wano, Y., Franza, B., & Greene, W. (1988) · Science · doi:10.1126/science.241.4873.1652 · Cited by 176
Lenardo, M. J., Kuang, A. A., Gifford, A. M., & Baltimore, D. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.23.8825 · Cited by 147
Edbrooke, M. R., Burt, D. W., Cheshire, J. K., & Woo, P. M. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.5.1908 · Cited by 136
A negative transcriptional control element located upstream of the murine c‐myc gene.
Remmers, E. F., Yang, J.-P., & Marcu, K. B. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04301.x · Cited by 124
Regulatory elements that modulate expression of human c-myc.Preprint
Hay, N., Bishop, J. M., & Levens, D. (1987) · Genes & Development · doi:10.1101/gad.1.7.659 · Cited by 124
Specific regulation of c-myc oncogene expression in a murine B-cell lymphoma.
McCormack, J. E., Pepe, V. H., Kent, R. B., Dean, M. C., Marshak‐Rothstein, A., & Sonenshein, G. E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.17.5546 · Cited by 92
Self-citationTrans-acting elements modulate expression of the human c-myc gene in Burkitt lymphoma cells.
Chung, J. H., Sinn, E., Reed, R. R., & Leder, P. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.20.7918 · Cited by 83
Transcriptional and posttranscriptional control of c-myc gene expression in WEHI 231 cells.
Levine, R. A., McCormack, J. E., Buckler, A., & Sonenshein, G. E. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.11.4112 · Cited by 79
Self-citationMason, P. J., Elkington, J. A., Lloyd, M. M., Jones, M. B., & Williams, J. G. (1986) · Cell · doi:10.1016/0092-8674(86)90743-9 · Cited by 60
Cited by
Aberrant rel/nfkb genes and activity in human cancer
Rayet, B., & Gélinas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203221 · Cited by 1,110
Reactive oxygen species in tumor progression
Storz, P. (2005) · Frontiers in Bioscience · doi:10.2741/1667 · Cited by 957
IMF-κB and Rel: Participants in a Multiform Transcriptional Regulatory System
Grilli, M., Chiu, J. J.-S., & Lenardo, M. J. (1993) · International Review of Cytology · doi:10.1016/s0074-7696(08)61873-2 · Cited by 936
Victora, G. D., & Nussenzweig, M. C. (2022) · Annual Review of Immunology · doi:10.1146/annurev-immunol-120419-022408 · Cited by 824
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A., & Neumeier, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118598 · Cited by 798
Metadata
- Authors
- Duyao, M. P., Buckler, A. J., & Sonenshein, G. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1990-06
- Volume
- 87
- Issue
- 12
- Pages
- 4727-4731
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2003609549
- Cited by
- 278
- References
- 28
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.